Clincosm LogoSign in Get a demo

her2 positive breast cancer

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2 Positive Breast Cancer Trial in Worldwide (Tucatinib, Trastuzumab, Pertuzumab)

Recruiting
  • HER2 Positive Breast Cancer
  • Phoenix, Arizona
  • +143 more
Jan 20, 2023

HER2 Positive Breast Cancer Trial in United States (tucatinib, trastuzumab deruxtecan)

Recruiting
  • HER2 Positive Breast Cancer
  • Birmingham, Alabama
  • +32 more
Oct 26, 2022

Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive Trial (Neratinib, Loperamide, Colesevelam)

Not yet recruiting
  • Early-stage Breast Cancer
  • +2 more
  • (no location specified)
Aug 5, 2022

HER2 Positive Breast Cancer Trial in Ireland (Copanlisib, Trastuzumab)

Completed
  • HER2 Positive Breast Cancer
  • Cork, Ireland
  • +4 more
Jul 25, 2022

Carcinoma Breast Stage I, HER2 Positive Breast Cancer Trial in Mumbai (Trastuzumab, Placebo)

Recruiting
  • Carcinoma Breast Stage I
  • HER2 Positive Breast Cancer
  • Mumbai, India
    Tata Memorial Centre
Apr 26, 2022

HER2 Positive Breast Cancer Trial in Worldwide (HD201, Herceptin, Docetaxel)

Completed
  • HER2 Positive Breast Cancer
  • Minsk, Belarus
  • +14 more
Apr 21, 2022

Exosomal and Free Extracellular RNAs and Proteins as Predictive

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Biomarker Analysis
  • Cork, Ireland
  • +10 more
Oct 8, 2021

Breast Cancer Female NOS, Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II Trial in Berlin (Denosumab,

Completed
  • Breast Cancer Female NOS
  • +6 more
  • Berlin, Germany
    Charité Campus Mitte
Feb 1, 2021

HER2 Positive Breast Cancer Trial in Guangzhou (lapatinib and capecitabine or vinorelbine)

Completed
  • HER2 Positive Breast Cancer
  • lapatinib and capecitabine or vinorelbine
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 13, 2020

HER2 Positive Breast Cancer Trial in Zhengzhou (Pyrotinib plus trastuzumab and docetaxel and carboplatin)

Recruiting
  • HER2 Positive Breast Cancer
  • Pyrotinib plus trastuzumab and docetaxel and carboplatin
  • Zhengzhou, Henan, China
    Henan cancer hospital
Apr 23, 2020

HER2 Positive Breast Cancer Trial (Pyrotinib and Trastuzumab plus Vinorelbine)

Unknown status
  • HER2 Positive Breast Cancer
  • Pyrotinib and Trastuzumab plus Vinorelbine
  • (no location specified)
May 13, 2019

Tubular Breast Cancer Stage II, Tubular Breast Cancer Stage III, Mucinous Breast Cancer Stage II Trial in Heidelberg

Completed
  • Tubular Breast Cancer Stage II
  • +6 more
  • non-pegylated liposomal doxorubicin
  • +7 more
  • Heidelberg, Baden-Württemberg, Germany
    NTC
Jul 10, 2017

Breast Cancer, HER2 Positive Breast Cancer Trial in Worldwide (MM-302, Gemcitabine, Capecitabine)

Terminated
  • Breast Cancer
  • HER2 Positive Breast Cancer
  • Glendale, Arizona
  • +108 more
Jan 4, 2017

Breast Cancer, HER2 Positive Breast Cancer, Metastatic Breast Cancer Trial in Spain, United States (IPI-504, Trastuzumab)

Terminated
  • Breast Cancer
  • +3 more
  • Palm Springs, California
  • +10 more
Dec 7, 2012